THE SIGNIFICANCE OF CD43, CD81, CD200, AND ROR1 FOR DIFFERENTIAL DIAGNOSIS OF CLL AS MULTICOLOR FLOW CYTOMETRY

EHA Library, Mesude Falay, 267864

FEATURES OF CYSTEIN-RICH PROTEIN METALLOTHIONEIN FUNCTIONING IN CHRONIC B-LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Yuliya Harmaza, 267865

PROGNOSTIC VALUE OF MICRORNA-223 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Olga Berezina, 267866

INFECTIOUS RISK AND HYPOGAMMAGLOBULINEMIA IN A MONOCENTRIC REAL LIFE COHORT OF 211 CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS FOLLOWED FOR 25 YEARS

EHA Library, Roberta Murru, 267867

ATYPICAL CHRONIC LYMPHOCYTIC LEUKEMIA HAS A WORSE PROGNOSIS THAN CLL AND SHOWS DIFFERENT CLINICAL AND LABORATORY FEATURES FROM B-CELL PROLYMPHOCYTIC LEUKEMIA

EHA Library, Ari Ahn, 267868

SAFETY AND EFFECTIVENESS OF CHLORAMBUCIL-OBINUTUZUMAB IN THE FRONT LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: REAL-LIFE DATA FROM ANDALUSIAN LYMPHOID NEOPLASM GROUP (GRANEL)

EHA Library, José Manuel Puerta Puerta, 267869

CONCEPTUAL MODEL OF CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Daniel Eek, 267870

IBRUTINIB: INCREASED SUSCEPTIBILITY TO INFECTIONS AND USE OF RESOURCES ASSOCIATED

EHA Library, Cristina Alburquerque-Prieto, 267871

IBRUTINIB, SINGLE AGENT BTK INHIBITOR, FOR RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA: A REAL-WORLD EXPERIENCE FROM RETE EMATOLOGICA PUGLIESE (REP).

EHA Library, Nicola Cascavilla, 267872

THE BARCELONA-BRNO BIOMARKERS-ONLY PROGNOSTIC MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA - SINGLE CENTRE EXPERIENCE

EHA Library, Kristina Tomic, 267873

IMPROVEMENT IN PATIENT-REPORTED OUTCOMES (PROS) AND FATIGUE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB (IBR) MONOTHERAPY: REPORT OF REAL WORLD EXPERIENCE.

EHA Library, Maria Jose Mela Osorio, 267874

PROPHYLAXIS FOR OCCULT HBV INFECTION UNDER IBRUTINIB THERAPY: MANDATORY OR OPTIONAL?

EHA Library, Abdulkadir Ercaliskan, 267875

PREDICTIVE VALUE OF PERIPHERAL LYMPHOCYTES SUBPOPULATIONS ON BCR INHIBITORS ACTIVITY IN HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Massimiliano Gambella, 267876

FROM ACADEMY TO REAL WORLD: THE GRAY AREA OF THE LARGE GRANULAR LYMPHOCYTES LEUKEMIA

EHA Library, Harberth Fernandez Leyva, 267877

IBRUTINIB THERAPY IS ASSOCIATED WITH SERIOUS INFECTIONS IN PATIENTS WITH B-CELL MALIGNANCIES - A SINGLE CENTER EXPERIENCE

EHA Library, Karla Misura Jakobac, 267878

THE SIGNIFICANCE OF THE INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI) IN SERBIAN CLL PATIENTS

EHA Library, Vojin Vukovic, 267879

HYPOGAMMAGLOBULINEMIA AS A PREDICTOR OF SURVIVAL IN OLDER PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Elif Umit, 267880

ANALYSIS OF CLL PATIENTS TREATED WITH BCR AND BCL-2 INHIBITORS AND RICHTER TRANSFORMATION

EHA Library, Daniel Naya, 267881

THE CLINICAL EFFICACY OF IBRUTINIB IN RELAPSED AND RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Elena Kataeva, 267882

EFFICACY AND SAFETY OF RITUXIMAB BIOSIMILAR TRUXIMA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODGKIN’S LYMPHOMAS

EHA Library, Ilina Micheva, 267883

CIRS SCORE АS A RELIABLE COMORBIDITY EVALUATION TOOL MAY INFLUENCE THERAPEUTIC DECISIONS IN ELDERLY CLL PATIENTS

EHA Library, Gazmend Amzai, 267884

CD14 AS A POTENTIAL PROGNOSTIC FACTOR AND BCL-2 AS A THERAPEUTIC TARGET IN EGYPTIAN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS

EHA Library, Mohamed Elkhawanky, 267885

MIRNAS AND ANGIOGENIC FACTORS IN PLASMA BEFORE AND AFTER TKI TREATMENT IN CML PATIENTS

EHA Library, Zofia Ulańczyk, 267886

THE EXPRESSION OF LEVEL MIR203A GENE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN DIFFERENT PHASES OF DISEASE

EHA Library, Anna Lyamkina, 267888

EFFECT OF OCT1 GENE POLYMORPHISM ON RESPONSE TO IMATINIB MESYLATE IN CML PATIENTS

EHA Library, Mervat Omran, 267889

BCR-ABL GENE ABL KINASE DOMAIN MUTATIONS IN IMATINIB RESISTANT CHRONIC MYELOID LEUKEMIA PATIENTS FROM AZERBAIJAN

EHA Library, Chingiz Asadov, 267890

COMPREHENSIVE ANALYSIS OF MOLECULAR RESPONSE IN TUNISIAN CML PATIENTS FOR TREATMENT DISCONTINUATION

EHA Library, Rim Frikha, 267891

PONATINIB INDUCES A SUSTAINED DEEP MOLECULAR RESPONSE IN A CHRONIC MYELOID LEUKAEMIA PATIENT WITH AN EARLY RELAPSE WITH A T315I MUTATION FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Nuno Cerveira, 267892

COMPARATIVE STUDY OF GLIVEC VERSUS STATE SPONSORED GENERIC IMATINIB MESYLATE AS FIRST LINE THERAPY IN CHRONIC MYELOID LEUKEMIA- CHRONIC PHASE

EHA Library, Asif Iqbal, 267894

THE RELATIONSHIP BETWEEN OXIDATIVE STRESS LEVELS, BCR-ABL1 TRANSCRIPT VALUES AND TREATMENT WITH TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Mihnea-Alexandru Găman, 267895

BCR-ABL1/ABL REDUCTION RATIO SUPERIORITY OVER EMR AND HALVING TIME AS A PREDICTOR FOR OUTCOME IN EGYPTIAN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS

EHA Library, Mohamed Elbogdady, 267896

WITHDRAWAL SYNDROME AFTER TYROSINE KINASE INHIBITORS DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND DEEP MOLECULAR RESPONSE IN A MULTICENTER PROSPECTIVE STUDY (RU-SKI)

EHA Library, Anna Petrova, 267897

POTENTIAL DRUG-DRUG INTERACTIONS AMONG PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TYROSINE KINASE INHIBITOR THERAPY WITH IMATINIB

EHA Library, ahmad kunbaz, 267898

CORRELATION BETWEEN LEVELS OF EARLY MOLECULAR RESPONSE AND BCR-ABL TRANSCRIPT TYPE IN STABLE DMR ATTAINMENT IN CML PATIENTS TREATED WITH IMATINIB

EHA Library, Mario Tiribelli, 267899

CARDIO-ONCOLOGY UNIT IMPROVE THE MANAGEMENT OF TREATMENT WITH TKIS OF CHRONIC MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE.

EHA Library, Giuseppina SPINOSA, 267900

PREDICTIVE POWERS OF VARIOUS CARDIOVASCULAR EXAMINATIONS FOR CARDIOVASCULAR OCCLUSION EVENTS IN CML PATIENTS RECEIVING TYROSINE KINASE INHIBITORS

EHA Library, Mika Nakamae, 267901

CLINICAL FEATURES AND TREATMENT OUTCOMES OF CHRONIC PHASE-CHRONIC MYELOID LEUKEMIA PATIENTS IN TURKEY: REAL-WORLD DATA

EHA Library, Guray Saydam, 267902

REAL LIFE EXPERIENCE IN CML PATIENTS IN CANARY ISLAND

EHA Library, Maria Saez-Perdomo, 267903

EXPRESSION LEVELS OF PD-1 ON T CELLS IN CHRONIC MYELOID LEUKEMIA

EHA Library, Min Young Lee, 267904

CHROMOSOMAL ABERRATIONS IN CHRONIC MYELOID LEUKEMIA AND THEIR IMPACT ON RESPONSE TO CONVENTIONAL TYROSINE KINASE INHIBITORS AND RISK OF BLASTIC TRANSFORMATION.

EHA Library, Shafaq Maqsood, 267905

PERSPECTIVE OF THE PATIENT WITH CML AND FAILURE TO TREATMENT WITH IMATINIB AT AN ENVIROMENT OF LIMITED RESOURCES.

EHA Library, Karen Lorena Osorno-Rodríguez, 267906

ACCURACY AND SPEED OF REPORTING MOLECULAR RESPONSE IN PATIENTS ON TYROSINE KINASE INHIBITORS THERAPY WITH GENEXPERT CARTRIDGE-BASED BCR-ABL1 QUANTITATION

EHA Library, Mojca Dreisinger, 267907

PATIENT REPORTED OUTCOMES (PROS) SHOW SUPERIOR QUALITY OF LIFE (QOL) FOR CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH FIRST COMPARED TO NEWER GENERATIONS OF TYROSINE KINASE INHIBITORS (TKIS)

EHA Library, Adi Abulafia, 267908

SECOND GENERATION TKIS GUARANTEES A FASTER, DEEPER AND LONGER LASTING MOLECULAR RESPONSE COMPARED TO IMATINIB. AN ANALYSIS OF REAL LIFE

EHA Library, Luigia Luciano, 267909

EARLY CYTOTOXIC IMMUNE RESPONSE INCLUDING TUMOR SPECIFIC CYTOTOXIC T LYMPHOCYTES CAN BE OBTAINED IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH DASATINIB.

EHA Library, Tatsuro Jo, 267910

EXPERIENCE OF THE ANDALUSIAN CHRONIC MYELOID LEUKEMIA GROUP (GALMC) IN THE DISCONTINUATION OF THE TYROSINE KINASE INHIBITOR TREATMENT OUTSIDE OF CLINICAL TRIALS

EHA Library, Carolina ALARCÓN-PAYER, 267911

OUTCOMES FOLLOWING TREATMENT DISCONTINUATION IN CML: REAL-WORLD EXPERIENCE FROM 3 REGIONAL UK CENTRES

EHA Library, Marwan Kwok, 267912

COMPARISON OF EFFICACY AND SIDE EFFECTS OF SECONDLINE DASATINIB AND NILOTINIB THERAPIES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE RESISTANT OR INTOLERANT TO IMATINIB

EHA Library, Isik Kaygusuz Atagunduz, 267913

LONG-TERM CLINICAL OUTCOMES OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH IMATINIB AS INITIAL THERAPY

EHA Library, Masayuki SHISEKI, 267914

CHRONIC MYELOID LEUKEMIA PATIENTS WITH BOTH HIGH TH1 AND HIGH CD8+ T-CELL LEVELS SHOW THE BETTER REMISSION, AND THE GOOD THERAPEUTIC RESPONSE ACCOMPANIES WITH THE HIGHER TH1 LEVEL

EHA Library, Jingying Dai, 267915

GENERIC IMATINIB FOR THE TREATMENT OF CHRONIC MYELOID LEUKAEMIA- CLINICAL EXPERIENCE OVER A SIX YEAR PERIOD

EHA Library, Nikolaos Neokleous, 267916

THE LANDSCAPE OF BCR-ABL MUTATIONS UNDER TYROSINE KINASE INHIBITOR THERAPY IN A SINGLE INSTITUTE

EHA Library, Sheng-Hsuan Chien, 267917

ADDITIONAL CYTOGENETIC ABNORMALITIES IN RESOURCE CONSTRAINT COUNTRIES; AN ADDITIONAL BURDEN ON CHRONIC MYELOID LEUKEMIA PATIENTS?

EHA Library, Nida Anwar, 267918

QUALITY OF LIFE AND SYMPTOM BURDEN WITH FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

EHA Library, Tayfur Toptas, 267919

DETECTION OF COMPLEX VARIANT T(9;22) CHROMOSOME TRANSLOCATIONS IN NEWLY DIAGNOSED CASES OF CHRONIC MYELOID LEUKAEMIA

EHA Library, Noorulain fareed, 267920

EVALUATION OF HEMATOLOGICAL AND NONHEMATOLOGICAL COMPLICATIONS OF IMATINIB MESILATE (IM) IN PATIENTS WITH PHILADELPHIA POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (PH+ CML)

EHA Library, Anahit Ter-Grigoryan, 267921

SUDDEN ONSET HEARING AND VISUAL LOSS: AN UNUSUAL PRESENTATION OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

EHA Library, Sanjeev Yadav, 267922

THE ROLE OF FLOW CYTOMETRY IN DIFFERENTIAL DIAGNOSIS OF CMML AND REACTIVE MONOCYTOSIS. THE LIPID SIGNAL PATHWAY CHARACTERISTICS IN CLONAL MONOCYTOSIS

EHA Library, Anna SEVOYAN, 267923

THREE CHRONIC MYELOID LEUKEMIA CASES THAT PRESENTED LIKE ESSENTIAL THROMBOCYTHEMIA

EHA Library, vedat aslan, 267924

THE HIGH INCIDENCE OF MICROCYTOSIS IN THE CONTEXT OF MONOCLONAL PERIPHERAL BLOOD LYMPHOCYTOSIS IN THE LEUKEMIC PHASE OF LYMPHOPROLIFERATIVE DISORDERS

EHA Library, Marta isabel de Correia Pereira, 267925

CHARACTERISTICS OF NEWLY DIAGNOSED AUTOIMMUNE HEMOLYTIC ANEMIA: 5-YEARS OF SINGLE-CENTER EXPERIENCE

EHA Library, Drazen Pulanic, 267926

CLINICAL UTILITY OF RETICULOCYTE HEMOGLOBIN EQUIVALENT TO DIFFERENTIATE BETWEEN FUNCTIONAL IRON DEFICIENCY ANEMIA AND TRUE ANEMIA AND DIFFERENT FROM ANEMIA OF OTHER CAUSES OF CHRONIC DISEASE.

EHA Library, ENNA MARIA LOURENCO, 267927

HEREDITARY ELLYPTOCYTOSIS ASSOCIATED WITH HETEROZYGOTE PYRUVATE KINASE AND GLUCOSE-6-PHOSPHATE DEHIDROGENASE MUTATIONS. A CASE REPORT AND FAMILY STUDY

EHA Library, Salvador PAYÁN PERNÍA, 267928

TWO NEW MUTATIONS AND MOLECULAR CHARACTERIZATION OF G6PD GENE AMONG THAI CHILDREN WITH G6PD DEFICIENCY

EHA Library, Chanchai Traivaree, 267929

CYP2D6 ALLELIC CHARACTERIZATION ON SPANISH TYPE 1 GAUCHER DISEASE PATIENTS

EHA Library, Laura López De, 267930

AUOTOIMMUNE HEMOLITIC ANEMIA (AIHA) IN CHILDHOOD. IS PRIMARY IMMUNE DISORDERS MORE OFTEN THAN EXPECTED IN ETIOLOGY OF SECONDARY AIHA

EHA Library, Turkan Patıroglu, 267931

STEPWISE APPROACH TO UNDIAGNOSED ANEMIA IN CHILDREN: A MODEL FOR LIMITED RESOURCES SETTINGS

EHA Library, Iman Ragab, 267932

RIBOCICLIB INDUCES MACROCYTOSIS IN THERAPEUTIC DOSES: CHARACTERIZATION OF OUTCOME

EHA Library, Solange Alves, 267933

CONTRIBUTION OF NGS IN THE DIAGNOSIS OF HEREDITARY SPHEROCYTOSIS : CASE REPORT

EHA Library, Géraldine Verstraete, 267934

PYRUVATE KINASE DEFICIENCY IN FOUR CHILDREN WITH TWO UNPUBLISHED MUTATIONS

EHA Library, Turkan Patıroglu, 267935

CHRONIC FATIGUE, ANAEMIA AND MUSCULOSKELETAL AFFECTATION IN GAUCHER DISEASE

EHA Library, Pilar Giraldo Castellano, 267936

MICROANGIOPATHIC HEMOLYTIC ANEMIA DUE TO HEART VALVE PROSTHESIS

EHA Library, Dino Luís, 267937

HEREDITARY ELLIPTOCYTOSIS WITH NEONATAL TRANSIENT POIKILOCYTOSIS VS HEREDITARY PYRO POIKILOCYTOSIS - THE SAME PRESENTATION... A DISTINCT CLINICAL COURSE

EHA Library, Dino Luís, 267938

ONLINE CME AS A TOOL TO INCREASE CLINICIANS’ KNOWLEDGE OF CLINICAL TRIAL DATA FOR GENE THERAPY IN HEMOPHILIA

EHA Library, Simi Hurst, 267939

IMPROVING HEALTHCARE PROVIDERS’ KNOWLEDGE REGARDING THE PRINCIPLES OF GENE THERAPY FOR HEMOPHILIA THROUGH ONLINE EDUCATION

EHA Library, Simi Hurst, 267940

RESULTS OBTAINED FROM CLINICAL TRIALS PHASE I/II IN HEMATOLOGICAL MALIGNANCIES. CLINICAL EXPERIENCE OF A SINGLE CENTER: HOSPITAL 12 OCTUBRE.

EHA Library, Clara Cuéllar Pérez-Ávila, 267941

AN IN VITRO STUDY OF THE INTERACTIONS BETWEEN THE CELL BASED CANCER VACCINE DCP-001 AND ANTIGEN PRESENTING CELLS

EHA Library, Satwinder Kaur Singh, 267942

OUTCOMES WITH EXTRACORPOREAL PHOTOPHERESIS IN THE MANAGEMENT OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION: A SINGLE-CENTRE EXPERIENCE

EHA Library, David ROUTLEDGE, 267944

THE INFLUENCE OF IL1B PROMOTER METHYLATION PROFILE ON FUNCTIONAL STATE OF HEMATOPOIETIC MICROENVIRONMENT

EHA Library, Dmitriy Karpenko, 267945

BLOOD CELL PRODUCTION IS NOT INFLUENCED BY BONE HEALTH STATUS IN HOMOEOSTASIS - THE COLAUS/OSTEOLAUS COHORT

EHA Library, Frédérica Schyrr, 267946

SELECTIVE ACTIVATION OF TOLEROGENIC CELL DEATH PATHWAYS IN MESENCHYMAL STROMAL CELLS

EHA Library, Roberto savoldelli, 267947

CANCER-ASSOCIATED MECHANISMS OF MESENCHYMAL STEM CELLS REVEALED BY SINGLE-CELL TRANSCRIPTOME ANALYSIS

EHA Library, John Zhong, 267948

HARLEQUIN CELL: UBIQUITOUS OR PATHOGNOMIC???

EHA Library, Garima Jain, 267949

HEMATOPOIETIC LIKE CELLS DERIVED FROM CANCER STEM CELLS GENERATED FROM MOUSE INDUCED PLURIPOTENT STEM CELLS: NOVEL CONCEPT FOR CANCER ASSOCIATED HEMATOPOIESIS

EHA Library, Ghmkin Hassan, 267950

HEMATOPOIETIC STEM CELL EXPANSION IN THE PRESENCE OF NICOTINE AMIDE AND IN THE MICROFLUIDIC DEVISE AND THE DBM SCAFFOLD

EHA Library, Maryam Asgari, 267951

THE EFFECTS OF ANTITUMOR THERAPY ON BONE REMODELING IN PATIENTS WITH HODGKIN'S LYMPHOMA

EHA Library, Mariya Voytko, 267952

FREQUENCY OF ABERRANT PHENOTYPE AND HISTIOCYTIC MARKER CD163 AND ITS PROGNOSTIC RELATIONSHIP IN A COHORT OF PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA IN THE NATIONAL CANCER INSTITUTE OF MEXICO (INCAN)

EHA Library, Liliana Moreno, 267953

PROGNOSTIC VALUE OF PRETRANSPLANT PET/CT IN HODGKIN LYMPHOMA

EHA Library, Zsófia Dr Miltényi, 267954

SECOND MALIGNANCIES IN LYMPHOMA SURVIVORS: A SINGLE CENTER EXPERIENCE

EHA Library, Maria Pina Simula, 267955

OUTCOME OF PEDIATRIC NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA, IS ABVD THE BEST REGIMEN ? 10 YEARS SINGLE CENTER EXPERIENCE, REPORT FROM CHILDREN CANCER HOSPITAL, EGYPT.

EHA Library, Youssef Madney, 267956

MANAGEMENT OF CLASSICAL HODGKIN LYMPHOMA IN MOROCCO: A MONOCENTRIC RETROSPECTIVE STUDY

EHA Library, Mounir Ababou, 267957

IMPACT OF AUTOIMMUNE CYTOPENIAS ON THE CLINICAL COURSE AND SURVIVAL OF HODGKIN LYMPHOMA

EHA Library, László Pinczés, 267958

ADDED RADIOTHERAPY IMPROVES PROGNOSIS IN HD PATIENTS TREATED WITH ABVD

EHA Library, Oliver Karanfilski, 267959

A 15 YEAR RETROSPECTIVE STUDY OF HODGKIN LYMPHOMA PATIENTS IN ALBANIA

EHA Library, Alma Cili, 267960

LONG TERM SURVIVORS HODGKIN’S LYMPHOMA: A SINGLE CENTER EXPERIENCE

EHA Library, Francesco Gaudio, 267961

BRENTUXIMAB VEDOTIN PLUS BENDAMUSTINE IN RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: A SINGLE CENTER EXPERIENCE

EHA Library, Bahar Uncu Ulu, 267962

PRELIMINARY RESULTS OF USING BRENTUXIMAB VEDOTIN IN RELAPSE/REFRACTORY HODGKIN’S LYMPHOMA.

EHA Library, Akmaral Jazyltayeva, 267963

PERIPHERAL BLOOD INVOLVEMENT BY FLOW CYTOMETRY IS NOT AN UNUSUAL FEATURE IN IGM MGUS/WALDENSTRÖM MACROGLOBULINEMIA WITH MYD88 L265P MUTATION.

EHA Library, Sara Montesdeoca, 267964

DETECTING MANTLE CELL LYMPHOMA MINIMAL RESIDUAL DISEASE IN AUTOLOGOUS GRAFT THROUGH NEXT-GENERATION SEQUENCING AND THE IMPLICATION ON LONG-TERM REMISSION

EHA Library, Yu-Hung Wang, 267965

UNDERSTANDING CIRCULATING LARGE GRANULAR LYMPHOCYTIC PROLIFERATIONS IN CUTANEOUS T-CELL LYMPHOMA

EHA Library, Yumeng Zhang, 267966